May 14, 2008
Solvay launches new product for air pollution control
Investing USD 40 Million in Innovative Technology to Manufacture SOLVAir ® Select 300 for Flue Gas Treatment [EN]-[FR]-[NL]
May 13, 2008
First quarter 2008 results
Operating results for the Solvay Group in the 1st quarter of 2008 : -8% compared to the high level of the 1st quarter of 2007. An increase of 12% compared to the 4th quarter of 2007. Net income of the Group (eur 220 million) up by 1%. [EN]-[FR]-[NL]
May 13, 2008
Annual Shareholders Meeting 2008
Speeches by the Chairmen - Toespraken van de Voorzitters - Discours des Présidents [EN]-[FR]-[NL]
May 08, 2008
Solvay to power its Bernburg (Germany) plant with secondary solid fuels
Energy generated from Refuse Derived Fuel Available in 2010 [EN]-[FR]-[NL]
April 25, 2008
SOLVAY PHARMACEUTICALS S.A. LAUNCHES FRIENDLY BID TO ACQUIRE INNOGENETICS
Building on a successful R&D co-operation [EN]-[FR]-[NL]
March 31, 2008
Phase III studies of investigational Trilipix™ (SLV348/ABT-335), in combination with statins, meets primary endpoints on improving LDL, triglycerides and HDL
TriLipix™ in combination with statins improved all three key lipids and had reported safety consistent
with TriLipix™ or statin monotherapies
[EN]-[FR]-[NL]
March 12, 2008
FDA approval of Abbott's SIMCOR® marks start of co-promotion with Solvay
FDA Decision Triggers Milestone Payment of USD 100 million by Solvay to Abbott [EN]-[FR]-[NL]
March 06, 2008
Solvay finalized sale of polypropelene compounding activity to Lyondellbasell
Solvay announces today that it has finalized the sale of 100% of its subsidiary Solvay Engineered Polymers (SEP), a major supplier of polypropylene compounds, to LyondellBasell Industries. [EN]-[FR]-[NL]
March 03, 2008
Fournier Laboratories Ireland Ltd and Laboratoires Fournier SA filed patent infringement actions against Teva in the USA
Fournier Laboratories asserts intellectual property of TriCor® (fenofibrate) 145mg NFE [EN]-[FR]-[NL]
February 29, 2008
Solvay Pharmaceuticals S.A. acknowledges decision of Wyeth Pharmaceuticals to terminate the collaboration agreement on bifeprunox
Solvay Pharmaceuticals will evaluate all options for the future of the compound [EN]-[FR]-[NL]
February 15, 2008
2007 Results
Record operating results for Solvay in 2007 of EUR 1.2 billion, up 9% from 2006 [EN]-[FR]-[NL]
February 01, 2008
Sale of Solvay’s Caprolactones business to Perstorp confirmed
Transaction Received European Commission Antitrust Clearance [EN]-[FR]-[NL]
January 23, 2008
Fournier Laboratories Ireland Ltd was informed of anda filing for generic Tricor® in the USA
An Attempt to Seek Approval for a Generic Version of TriCor® 145mg NFE Tablets [EN]-[FR]-[NL]
December 14, 2007
Solvay Indupa will produce bioethanol-based vinyl in Brasil & considers state-of-the-art power generation in Argentina
Polyvinyl chloride (PVC) Derived from Sugar Cane and Salt [EN]-[FR]-[NL]
November 30, 2007
Solvay Science for Innovation Conference focuses on the creation of novel, complex materials
Nobel Prize Winners Lehn and Laughlin Address Solvay Researchers [EN]-[FR]-[NL]
November 29, 2007
Solvay signs agreement to sell polypropylene compounding activity to Basell
Focusing on activities where the Group has better opportunities to create business value [EN]-[FR]-[NL]
November 07, 2007
New clinical data show Solvay’s fenofibrate cuts risk of main causes of vision loss in patients with type 2 diabetes
Fenofibrate offers opportunity to protect patients from most serious consequences of type 2 diabete [EN]-[FR]-[NL]
October 30, 2007
SolVin Awards acclaim vinyl innovators at K2007 for environmental, design and safety achievements
The winners of the 2007 SolVin Awards for PVC Innovation were unveiled yesterday during the K2007 International Plastics Trade Fair in Düsseldorf, Germany, honouring the most impressive innovators among 107 contestants which represented the entire vinyl value chain. [EN]
October 29, 2007
Solvay takes steps to resume growth and restore competitiveness of its Fluor Chemicals business
Focusing on high value added specialties, downsizing production of commodities [EN]-[FR]-[NL]
October 26, 2007
Nine months 2007 results
Solvay’s operating results (EUR 925 million) 5% above the excellent results from the first 9 months of 2006 (+8% in the 3rd quarter) [EN]-[FR]-[NL]
October 24, 2007
Solvay Unveils 'More Plastics with More Performance' at K2007 International Plastics Trade Fair
Solvay announces today that it has unveiled a number of innovative products at a press conference on the opening of the K2007 International Plastics Trade Fair in Düsseldorf, Germany, including the new family of SolvivaTM Biomaterials available for use in implantable medical devices as well as extensions to its Hyflon® and Tecnoflon® fluoropolymers ranges. [EN]-[FR]-[NL]
October 22, 2007
Abbott and Solvay Pharmaceuticals to co-promote Abbott's SIMCOR® in the United States
Solvay Pharmaceuticals has entered into an agreement granting Solvay select co-promotion rights in the United States for Abbott's investigational fixed-dose combination lipid therapy, SIMCOR® (Niaspan®/simvastatin), currently awaiting U.S. Food and Drug Administration (FDA) approval. [EN]-[FR]-[NL]
October 17, 2007
Pipelife starts up production in new russian factory
Solvay Affiliate Expands into One of Europe’s Fastest Growing Markets [EN]-[FR]-[NL]
October 15, 2007
Solvay signs agreement to sell Caprolactones business to Perstorp
Focusing on activities where the Group has maximum control over raw materials [EN]-[FR]-[NL]
October 08, 2007
China : Solvay reinforces its presence and plans for more investments in specialty polymers
PTFE Micronized Powder facility confirmed; more projects under consideration [EN]-[FR]-[NL]
September 26, 2007
Solvay Investors Day
Presentations [EN]
September 24, 2007
Solvin to expand PVDC latex production in world-class plant of Tavaux (France)
A timely, competitive response to serve growing demand from food & pharma industry [EN]-[FR]-[NL]
September 06, 2007
Solvay to build world-class Epicerol® plant in Thailand
Innovative green chemistry technology to serve strong demand for epichlorohydrin [EN]-[FR]-[NL]
August 30, 2007
Solvay expands printed electronics development platform with investment in Plextronics
Innovative Technology for Mass-Production of Displays, Lighting, Solar Cells and ‘Smart’ Labels [EN]-[FR]-[NL]
August 14, 2007
Solvay launches Peracetic Acid production in China
State-of-the-Art Proxitane® Plant now fully operational in Suzhou [EN]-[FR]-[NL]
August 10, 2007
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals announce receipt of an FDA action letter for bifeprunox, an investigational treatment for schizophrenia
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced today the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an atypical antipsychotic that was reviewed for the acute treatment of schizophrenia, as well as the maintenance of stable adult patients. [EN]-[FR]-[NL]
July 30, 2007
Dow and Solvay Form Joint Venture to Build Hydrogen Peroxide Plant in Thailand; Dow and BASF Continue to Pursue Plans for Thailand HPPO Plant [EN]-[FR]-[NL]
July 27, 2007
First half 2007 results
Solvay’s operating results of EUR 616 million for the 1st half of 2007, exceeding the excellent results for the 1st half of 2006 [EN]-[FR]-[NL]
July 24, 2007
SOLVIN moves to reap sustainable benefits from dynamic vinyls market
Focus on highly competitive production units [EN]-[FR]-[NL]
June 28, 2007
SOLVAY, SIBUR sign join venture agreement to build Russia’s first world-scale vinyls production plant
State-of-the art technology for a fast-growing market [EN]-[FR]-[NL]
June 22, 2007
Solvay Sodi expands soda ash production capacity in Devnya (Bulgaria) to provide for the growth of its clients
10th Anniversary of Privatization Highlights Success Story [EN]-[FR]-[NL]
June 14, 2007
Solvay and Thin Film Electronics sign agreement to develop and optimize materials for printed memories
Printed electronics pave way for major technological breakthrough with multiple new applications [EN]-[FR]-[NL]
May 22, 2007
With the Queen Elisabeth Medical Foundation, Solvay supports the fight against Charcot-Marie-Tooth disease
The quest to treat more effectively a neuro-degenerative disorder that affects one person in 2,500 [EN]-[FR]-[NL]
May 08, 2007
First quarter 2007 results
Further growth in operating results for the Solvay Group : +11% in the first quarter of 2007 [EN]-[FR]-[NL]
May 08, 2007
Annual Shareholders Meeting 2007
Speeches by the Chairmen - Toespraken van de Voorzitters - Discours des Présidents [EN]-[FR]-[NL]
May 07, 2007
Inergy Automotive Systems deploys its fuel systems business in China, India and Russia
The Solvay / Plastic Omnium joint venture supplies its automotive customers on strong-growth markets [EN]-[FR]-[NL]
May 02, 2007
Solvay Solexis expands Polyvinyledene fluoride (PVDF) production capacity in Tavaux (France)
Marketing and R&D efforts boost demand for SOLEF® [EN]-[FR]-[NL]
April 25, 2007
Solvay Pharmaceuticals files TEDISAMIL, a new cardiometabolic product for the treatment of atrial fibrillation and atrial flutter
Solvay announced today that its dossier for intravenous tedisamil (intended brand name: PULZIUM® IV), a new chemical entity coming from Solvay Pharmaceuticals R&D laboratories, has been filed for approval by the US Food and Drug Administration (FDA) as well as by the authorities of European Union countries. This means that the formal processing and review have begun. [EN]-[FR]-[NL]
April 05, 2007
Solvay’s green chemistry technology for the manufacturing of Epichlorohydrin is operational in Tavaux (France)
Group consolidates technological leadership of Epicerol™ process [EN]-[FR]-[NL]
April 02, 2007
Solvay affiliate Pipelife acquires Quality Plastics, a specialty pipes & fittings manufacturer
Pipelife reinforces product portfolio in fast-growing market, broadens geographical [EN]-[FR]-[NL]
March 30, 2007
SolVin considers new PVDC latex production unit
Serving Growing demand for barrier material [EN]-[FR]-[NL]
February 22, 2007
Solvay Solexis expands perfluoropolyethers (PFPE) production capacity in Spinetta Marengo (Italy)
Strong demand & growth prospects for innovative products Solvera®, Fluorolink® & H-Galden® [EN]-[FR]-[NL]
February 19, 2007
Solvay statement on press article published in « Vers l’Avenir” on February 19, 2007 [EN]-[FR]
February 15, 2007
2006 Results
2006 : another record year for Solvay,due to strong growth in operating performance. Growth in sales of 10% and in operating results of 21% [EN]-[FR]-[NL]
January 11, 2007
Solvay and Wyeth collaborate for discovery of anti-psychotics with novel mechanisms
Expansion of existing neuroscience agreement [EN]-[FR]-[NL]
December 23, 2006
Solvay statement on protection measures for workers exposed to Vinyl Chloride (VCM) [EN]-[FR]-[NL]
December 20, 2006
Solvay Innovation Trophy honors breakthrough technologies, social & environmental responsibility
Eight innovations developed within the Solvay group were distinguished During the Solvay Innovation Trophy (SIT) ceremony which took place today at Solvay headquarters in Brussels. [EN]-[FR]-[NL]
December 15, 2006
Solvay & SolVin partners in the “SANTO” expedition to the Vanuatu Islands: the most ambitious international scientific mission in the field of biodiversity
In partnership with the Royal Belgian Institute of Natural Sciences, the Solvay Group and SolVin are pleased to announce their participation in the most ambitious international scientific mission ever undertaken in the field of biodiversity: the SANTO 2006, Biodiversity in danger expedition to the island of Santo, one of the Vanuatu Islands lying right in the middle of the South Pacific. [EN]-[FR]-[NL]
December 11, 2006
Solvay Pharmaceuticals withdraws its marketing authorization application for SYNORDIA® in Europe
Solvay Pharmaceuticals announced today that its subsidiary, Fournier Laboratories Ireland Ltd, formally notified the European Medicines Agency (EMEA) of its decision to withdraw its application for a centralized marketing authorization for SYNORDIA® in Europe. [EN]-[FR]-[NL]
December 08, 2006
Solvay’s SLV 319 obesity candidate treatment advances in phase II clinical trials
Triggering a milestone payment from co-development and co-commercialization partner Bristol-Myers Squibb. [EN]-[FR]-[NL]
December 08, 2006
Mercury Electrolysis
Statement by Solvay regarding the report published in the Belgian press on 8 December 2006 [EN]-[FR]-[NL]
November 28, 2006
Solvay launches, environmentally-friendly biocide for eradication of life-threatening hospital ‘superbugs’
Perestane® effective against Clostridium difficile and MRSA [EN]-[FR]-[NL]
November 27, 2006
Solvin launches NANOVIN®, a vinyl nanocomposite ‘smart material’
Innovation opens new commercial opportunities [EN]-[FR]-[NL]
October 27, 2006
Nine months 2006 results
Excellent operating results from the Solvay Group for the first nine months of 2006, reflecting further sustained growth in the third quarter [EN]-[FR]-[NL]
October 27, 2006
Solvay interim dividend increases to EUR 0.80
New Calculation Method will Reflect Progress of Dividend [EN]-[FR]-[NL]
October 24, 2006
Solvay, Quintiles announce five-year renewal of drug development strategic alliance
Renewal reflects success of alliance, first formed in 2001, in accelerating Solvay pipeline [EN]-[FR]-[NL]
October 16, 2006
Solvay expands, upgrades ultra polymer production in Panoli (India)
Launch of KetaSpire™, a new polyether ether ketone (PEEK) product line [EN]-[FR]-[NL]
October 12, 2006
Solvay Pharmaceuticals and Wyeth announce submission of new drug application for Bifeprunox to treat schizophrenia
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announce today that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) for bifeprunox, an investigational, new generation atypical antipsychotic for treatment and maintenance of stability of schizophrenic patients. [EN]-[FR]-[NL]
October 11, 2006
Seven key electro-intensive companies active in Belgium propose innovative power sourcing mechanism
A group of 7 key electro-intensive industrial companies active in Belgium, called “Blue Sky Project” (Air Liquide Industries Belgium, Arcelor Mittal, BASF Antwerpen, Duferco, Solvay, Tessenderlo Chemie and Umicore), announces that it has designed and proposed an innovative power sourcing mechanism. [EN]-[FR]-[NL]
October 03, 2006
Solvay Investor Day
Presentations [EN]
September 27, 2006
BASF, Dow, Solvay partnership breaks new ground with innovative HPPO technology in Antwerp
Environmentally friendly plant reduces waste water and energy usage [EN]-[FR]
September 13, 2006
Solvay pioneers e-billing solution in Europe
An innovative customer oriented offering compliant with strict EU rules [EN]-[FR]-[NL]
August 31, 2006
Solvay joins advanced materials venture capital fund
Exploring new business developments in information and communications technologies [EN]-[FR]-[NL]
August 30, 2006
Solvay Indupa launches ambitious plan to expand and upgrade vinyls production in Brazil
Capacity increase in Santo Andre to meet fast-growing Latin American demand [EN]-[FR]-[NL]
August 21, 2006
Solvay to launch fluorochemicals production in China
Joint Venture Paves the Way for Development of High-Value Fluorine Business in Asia [EN]-[FR]-[NL]
July 28, 2006
First half 2006 results
Excellent operating results for the Solvay group in the 1st half of 2006, again reflecting strong growth
[EN]-[FR]-[NL]
July 25, 2006
Umicore and Solvay launch Solvicore to develop and supply core technology for fuel cell industry
Joint Venture for Membrane Electrode Assemblies (MEA) Started Operations [EN]-[FR]-[NL]
July 19, 2006
Solvay submits Synordia®
( fenofibrate/ metformin) for EU approval
Building out the fenofibrate franchise with a new fixed-dose combination product [EN]-[FR]-[NL]
July 14, 2006
Egeplast acquires innovative Solvay technology
for high resistance, fully recyclable tubing
Solvay announces today that it has concluded an agreement for the transfer of its HexelOneTM reinforced plastic pipe technology to Egeplast Werner Strumann GmbH & Co. KG, the German polyethylene pipes manufacturer. [EN]-[FR]-[NL]
July 12, 2006
Solvay Pharmaceuticals Settles Lawsuit against Pseudo-Generic to CREON® MINIMICROSPHERES®
Solvay announces today that its United States subsidiary Solvay Pharmaceuticals, Inc. has settled a lawsuit filed against Global Pharmaceuticals and Impax Laboratories, Inc. alleging that the companies falsely advertised and marketed their products as generic equivalents to and substitutes for Solvay Pharmaceuticals’ CREON® MINIMICROSPHERES® (Pancrelipase Delayed-release Capsules, USP).
[EN]-[FR]-[NL]
July 05, 2006
Solvay welcomes Abbott & Astrazeneca deal to develop for the United States a new single pill combination therapy for comprehensive lipid management
Endorsing the Future Value of the Fenofibrate Franchise [EN]-[FR]-[NL]
June 30, 2006
Solvay to launch specialty polymer production in China
PTFE Micronized Powder Facility to Serve Buoyant Asian Markets [EN]-[FR]-[NL]
May 24, 2006
Success of Solvay EUR 500,000,000 hybrid security issue
SOLVAY S.A, through its French, fully-owned subsidiary SOLVAY FINANCE S.A, today successfully priced EUR 500 million Bonds achieving a coupon of 6.375% over 10 years. [EN]
May 16, 2006
Solvay is founding member of Exeltium, the French grouping of electro-intensive industries: an innovative solution for sustainable control of energy costs
The Solvay group is pleased to participate in the foundation of Exeltium, the grouping of electro-intensive industries active in France, whose creation was announced yesterday by the French Ministry of the Economy, Finances and Industry. [EN]-[FR]-[NL]
May 15, 2006
Solvay completes acquisition of GHARDA, after Mississippi Polymer Technologies: expansion into ultra high performance polymers in India & U.S.
PEEK and Parmax® to Enhance Solvay Advanced Polymer’ Ultra Polymers Product Line [EN]-[FR]-[NL]
May 12, 2006
Solvay makes MEUR 75 million capital gain on sale of stake in S.A. Financière Keyenveld
Solvay announces that its subsidiary Mutuelle Solvay has sold today a shareholding of 49.6% in S.A. Financière Keyenveld to Union Financière Boël. [EN]-[FR]-[NL]
May 11, 2006
SolVin invests EUR 50 million to concentrate vinyl production on global size plants, optimizes logistics & product range
Competitiveness enhanced with larger capacities, innovative products [EN]-[FR]-[NL]
May 09, 2006
First Quarter 2006 Results
Excellent results for the Solvay Group in the 1st quarter of 2006 [EN]-[FR]-[NL]
May 09, 2006
Annual Shareholders Meeting 2006
Minutes & Speeches by the Chairmen - Notulen & Toespraken van de Voorzitters - Procès-verbaux & Discours des Présidents [EN]-[FR]-[NL]
May 08, 2006
Solvay Denies 2006 Profit Forecast Published in Belgian Newspaper De Tijd [EN]
May 04, 2006
Solvay Pharmaceuticals awarded $298 million, five-year contract by U.S. department of Health & Human Services for flu pandemic preparedness
Contract Covers Development of Cell-Based Influenza Vaccines and Planning for a U.S. Manufacturing Facility [EN]-[FR]-[NL]
May 03, 2006
Solvay considers appealing EC decision on Peroxygen competition case
Solvay was informed today about a European Commission decision to impose a fine in the aggregate of EUR 193 million on the Solvay Group in relation with a cartel in the peroxygen sector in the European Union, dating back to the end of the nineties. [EN]-[FR]-[NL]
April 03, 2006
Solvay closes sale of Industrial Foils Business to Renolit
SOLVAY SA announces today that it has closed on March 31st the sale of its Industrial Foils business to RENOLIT AG, following the relevant social procedures and approval of the European competition authorities. [EN]-
